You are using an older browser version. Please use a supported version for the best MSN experience.

Novavax COVID-19 Vaccine Proves to be Highly Effective in Late-Stage Trial

The American biotechnology company Novavax is set to offer the US a fourth COVID-19 vaccine. Veuer’s Maria Mercedes Galuppo has the story.
image beaconimage beaconimage beacon